Medicine and Public Health, School of Medicine, Keio University-Background: Recent case reports and epidemiological studies suggest that inhalation of indium dust induces lung damage. Objectives: To elucidate the dose-dependent effects of indium on the lungs and to prove a causal relationship more clearly. Methods: A baseline observation was conducted on 465 workers currently exposed to indium, 127 workers formerly exposed to indium and 169 workers without indium exposure in 12 factories and 1 research laboratory from 2003 to 2006. Indium in serum (In-S) was determined as an exposure parameter, and its effects on the lungs were examined. Results: The means of In-S in the current, former and no exposure workers were 8.35, 9.63 and 0.56 ng/ml, respectively. The current and former exposure workers had significantly higher levels of KL-6, and showed significant dose-dependent increases in KL-6, SP-D, and SP-A. Current exposure workers with In-S of 3 ng/ml or above demonstrated a significant increase of KL-6 in both GM and prevalence exceeding the reference value. Approximately a quarter of the former exposure workers had interstitial changes as seen on chest HRCT. In-S of exposed workers who had been working before improvements of the working environment (Group Bef) and those who started working after improvements (Group Aft) were 12.29 and 0.81 ng/ml, respectively. Adjusted odds ratios indicated 87%, 71% and 44% reductions among Group Aft workers who exceeded the reference values of KL-6, SP-D and SP-A, respectively. Conclusion: Dosedependent lung effects due to indium exposure were shown, and a decrease of indium exposure reduced the lung effects. An In-S value of 3 ng/ml may be a cut-off value which could be used to prevent early effects on the lungs. (J Occup Health 2009; 51: 513-521) 
Due to the rapid expansion of flat panel displays and solar cells, indium demand has increased every year, and in 2007, Japan consumed over 90% of the indium in the world 1) . Until the early 1990's, there was little information on the toxic effects of indium on humans or animals. In the mid 1990's, intra-tracheal instillation studies of particles of compound semiconductors such as indium phosphide, indium arsenide and indium trichloride revealed that metal compounds containing indium had a strong potential to induce severe lung damage [2] [3] [4] [5] [6] . In 2003, Homma et al. 7) disclosed a case of interstitial pneumonia in a 27-yr-old male worker engaged in the wet surface polishing process of indium-tin oxide (ITO) target plates, high-density plates made of very hard ceramics composed of indium oxide and tin oxide, which are used to laminate transparent electroconductive thin-film on flat displays and solar cells. The worker started this job in 1994, and at the beginning of 1998 was admitted to a hospital with the complaint of increasing dry cough and breathlessness. After a detailed medical examination, he was diagnosed with interstitial pneumonia, possibly caused by the inhalation of ITO particles. Up to the end of 2008, seven indium-induced cases of lung injury were disclosed [7] [8] [9] [10] [11] . After the first case was found, two epidemiological studies were performed in two different populations of indium-exposed workers 12, 13) . Both studies suggested strong relationships between indium in serum (In-S) and effects on the lungs.
After the first cross-sectional study 12) , we continued to make efforts to contact companies manufacturing indium products in order to inform the results of the health risk of indium compounds to their indium-exposed workers and to ask the workers to join our epidemiological survey. By the end of 2006, 13 factories and 1 research laboratory had agreed to join our epidemiological study.
Subjects and Methods

Study subjects
Among the 13 factories that participated, 1 factory studied by Chonan et al. 13) and 4 factories studied by Hamaguchi et al. 12) were included. Because the results of a pre-analysis of the remaining factories and the participating laboratory were compatible with the results of the two studies, we combined the data and analyzed all of them together. We informed all study candidates about the health risks of indium exposure and the purpose of the epidemiological study, and obtained their informed consent before they participated. The study was approved by the Ethical Committee, School of Medicine, Keio University. A total of 889 subjects gave their informed consent. We excluded one factory (n=93) from the analysis because In-S was determined by the factory's laboratory using a different detection limit. We obtained no data from 35 workers regarding their indium exposure or In-S. In total, we exclueded 128 workers, and analyzed 761 workers at 5 ITO manufacturing factories, 4 indium recycling factories, 3 indium oxide manufacturing factories, and 1 research laboratory consisting of 465 current indium exposure workers, 127 former indium exposure workers, and 169 no indium exposure workers. The no exposure workers worked at a factory that did not process indium or were office workers in indiumprocessing factories. The participation rate was 85.6% (761/889). Table 1 shows the characteristics of the study subjects. The majority of the subjects were male. The current exposure workers were significantly younger than the no exposure workers. The mean length of indium exposure was 55.1 mo (range: 0.25-455) in the current exposure workers and 60.4 mo (1-252) in the former exposure workers. The mean duration from the end of indium exposure in the former exposure workers was 58.3 mo (range 2-201). There were no significant differences in smoking histories among the three groups. Thirty-seven workers (14 current exposure, 10 former exposure, and 13 no exposure workers) had a history of asthma.
Exposure assessment
Most of the current and former exposure workers were exposed to multiple indium compound dusts such as ITO, indium trioxide, indium hydroxide, indium chloride, indium nitrate, and indium metal. Because information about the differences in the health effects of each indium compound is very limited, and the indium concentrations at the work sites could not be measured, we did not stratify the current and former workers by the species of indium compounds. We selected In-S as a quantitative biological marker of indium exposure 14) . In-S was determined by inductively coupled plasma mass spectrometry (ICP-MS) at the Center of Advanced Instrumental Analysis, Kyushu University and the Japan Industrial Safety and Health Association. The detailed procedure has been reported elsewhere 12, 13) . If the level of In-S was below the detection limit, 0.05 ng/ml was used for the statistical analysis.
As shown in Table 1 , the means of In-S in the current exposure, former exposure and no exposure workers were 8.35, 9.63 and 0.56 ng/ml , and the maximal concentrations were 116.9, 126.8, and 3.0 ng/ml, respectively. In-S in the current exposure and former exposure workers was significantly higher than in the no exposure workers.
To assess the dose-effect and dose-response relationships, the current and former exposure workers were classified into 6 groups by In-S referring to Chonan et al. 13) and Hamaguchi et al. 12) ; namely, workers with an In-S of 0.9 or below were assigned to Group 1, 1.0-2.9 to Group 2, 3.0-4.9 to Group 3, 5.0-9.9 to Group 4, 10.0- 19.9 to Group 5, 20.0 or above to Group 6.
Medical examinations
Respiratory symptoms and smoking habit were assessed using the Japanese version of the ATS-DLD questionnaire 15, 16) with some supplementary questions regarding past history of respiratory diseases and history of exposure to indium and other hazardous substances such as zinc, cadmium, lead, copper, gallium, selenium, etc.
Spirometry was performed using electronic spirometers (HI-701 or HI-801; Chest MI, Tokyo, Japan). Age-and height-adjusted predicted values of forced vital capacity (FVC) and forced expiratory volume in one second (FEV 1.0 ) were determined by the regression formula recommended by the Japanese Respiratory Society (JRS) 17) , and the rates (%) of observed/predicted values (%FVC, %FEV 1.0 ) were calculated. Statistical analysis was performed only for males because sex differences in pulmonary function are not negligible, and the number of female subjects was small. Serum KL-6 (Krebs von den Lungen-6) was measured in all study subjects 18) . Lung surfactant protein D (SP-D), lung surfactant protein A (SP-A), white blood cell count (WBC) and C-reactive protein (CRP) were measured for almost all subjects. For 44 subjects in 2 factories, the first and fifth high GM of In-S among 12 factories, serum biochemical tests for liver function (AST, ALT, γ-GTP), immunological function (IgE, IgG, IgM, IgA), and collagen disease (ANA, RF, ACE) were performed because some cases with indium-exposed lungs have shown mild liver dysfunction, and hypersensitive pneumonitis and collagen diseases are well known to cause interstitial change in the lungs. All tests were done at the Special Reference Laboratory, Tokyo, Japan, which is a nationwide clinical laboratory. Urinary 8-hydroxy-2'-deoxyguanosine(8-OH-dG) was measured by high performance liquid chromatography (HPLC) to assess oxidative stress on DNA in consideration of potential carcinogenicity 19) . High-resolution computed tomography (HRCT) of the lungs without a contrast agent was performed at the three levels of the lungs recommended by the JRS 20) , namely, the superior border of the aortic arch (upper lung field), the carina (middle lung field), and 1-3 cm above the right diaphragm (lower lung field). HRCT was performed mainly using a multi-slice CT scanner (Asteion 4, Toshiba Medical Systems Co., Tochigi) at 120 kV, 200 mA, and a slice thickness of 1 mm or a multi-slice CT scanner at hospitals near the factories. The scores of interstitial changes and emphysematous changes of the upper, middle, and lower lung fields of the right and left sides were assessed by two pulmonologists according to modified JRS guidelines for the diagnosis and management of chronic obstructive pulmonary disease (COPD) 20) . Namely, a score of 0 to 5 was given to each of the 6 lung fields when the area of interstitial or emphysematous changes occupied 0%, 1-9%, 10-24%, 25-49%, 50-74%, or more than 75% of each lung field assessed 20) . To estimate the prevalence of interstitial or emphysematous changes, a score of 2 or above in at least one of the 6 lung fields was analyzed, because the quality of the HRCT photographs was not sufficiently uniform due to differences in the CT equipment.
Statistical analysis
For continuous data, the data distribution was examined, and an appropriate transformation was performed to approximate a normal distribution before the analysis. The mean values of the variables were compared using the non-paired Student's t-test, Welch's t-test, or analysis of variance followed by Dunnett's test, if necessary, for adjusting multiple comparisons. Wilcoxon's rank sum test or the Mann-Whitney U test was applied when an appropriate transformation, such as interstitial change scores or emphysematous change scores, could not be applied. For categorical data, proportions were compared by the χ 2 test or Fisher's exact method followed by Bonferroni's method, if necessary, for adjusting multiple comparisons. Testing for trend was performed using a multiple regression model for continuous data and a logistic regression model for binary data. Age-, exposure duration-, and smoking-adjusted odds ratios were calculated according to exposure category by applying the logistic regression model. To assess statistical significance, two-tailed p<0.05 was used throughout the analyses. All statistical analyses were performed using SPSS version 15.0 J (SPSS Inc., Chicago, IL, USA). Table 2 shows the outcomes of the medical examinations according to exposure status. The geometric mean of KL-6 was significantly higher in the current exposure and former exposure workers than in the no exposure workers. The highest KL-6 levels of the current exposure and former exposure workers were 6,950 U/ml and 4,150 U/ml, respectively, which were 14 times and 8 times higher than the clinically applied reference value of KL-6 (<500 U/ml). Approximately a quarter of the current exposure and one-fifth of the former exposure workers exceeded the reference value, and the prevalences of KL-6 in the current exposure and former exposure workers were significantly higher than that in the no exposure workers. The prevalence of SP-D was also significantly higher in the current exposure workers than in the no exposure workers. SP-A was not significantly different among the three groups. Spirometry did not show any exposure-related changes in the current and former exposure workers, even after adjusting for smoking status. The former exposure workers showed a significantly higher prevalence rate of interstitial changes than the no exposure workers, and approximately a quarter of the former exposure workers showed evident interstitial changes. On the other hand, the emphysematous scores were not different among the current exposure, former exposure, and no exposure workers. The prevalence rates of cough and/or sputum in the current exposure and former exposure workers were significantly higher than in the no exposure workers. The results for the current exposure workers were very similar when workers with a history of asthma were excluded from the analysis, and when smoking status was stratified by current/ex-smokers and non-smokers. The current, former and no exposure workers showed prevalence rates of cough and/or sputum of 26.5%, 20.8%, and 10.4% in nonsmokers, and 29.6%, 28.4%, and 17.0% in smokers, respectively.
Results
Figures 1a-1d show scatter diagrams of log 10 (In-S) vs. KL-6 and SP-D for current and former exposure workers. Sharp dose-dependent increases in KL-6 and SP-D were seen in both the current and former exposure workers. Tables 3 and 4 show the means, prevalence of abnormal findings, and adjusted odds ratios (AOR) by In-S level in the current (Table 3) and former (Table 4) exposure workers. In the current exposure workers, the geometric mean, prevalence and AOR of KL-6 were significantly higher in groups with an In-S of 3.0 ng/ml or above than in no exposure workers, and the dose-dependent trend was statistically significant when a multiple regression model or a multiple logistic regression model was applied. The mean and prevalence of SP-D were also higher in groups with an In-S of 5.0 ng/ml or above than in no exposure workers, and the dose-dependent trend was also statistically significant. SP-A also increased dosedependently, and the geometric mean, prevalence and AOR were significantly higher in workers with an In-S of 5.0 ng/ml or above. In the former exposure workers, sharp dose-effect relationships of the biomarkers of interstitial changes were observed that were similar to those in the current exposure workers, and the dose-dependent trend was also statistically significant, although the former exposure workers had left their indium jobs for a period of 58.3 mo on average. Significant irreversible lung interstitial changes were seen in Groups 3, 5, and 6, and dosedependent trend was statistically significant. For 44 workers, serum biochemical tests for liver function, immunological function, and collagen disease and urinary 8-OH-dG were performed. We did not find any significant differences in these indices among the current, former and no exposure workers.
After we had intensively disseminated health risk information to the factories, they all began improving their working environments and using dust-protective masks to reduce indium inhalation. We asked them to report when they had finished implementing the first improvement in working conditions, and we were able to obtain this information from 12 factories. We categorized the current and former exposure workers in the 12 factories into 2 groups, one consisting of 379 workers who had been working before the improvements were implemented (Group Bef), and 109 workers who started working in a job involving indium after the improvements had been implemented (Group Aft). Average exposure durations were 67.1 mo and 17.3 mo in the Bef and Aft groups, respectively; mean ages were 37.6 yr and 33.0 yr in the Bef and Aft groups, respectively; and the male proportions were 94.2% and 83.3% in the Bef and Aft groups, respectively. These differences between the groups were all statistically significant. The smoking rate was not different between the Bef and Aft groups (71.2 and 66.1%). Table 5 shows the In-S and medical examination results for both groups. In-S was significantly lower in Group Aft than in Group Bef. KL-6, SP-D and SP-A were also significantly lower, and their prevalence rates were significantly lower in Group Aft than in Group Bef. Adjusted odds ratios indicated 87%, 71% , and 44% reductions of Group Aft workers exceeding the reference values of KL-6, SP-D , and SP-A, respectively. The pulmonary function and HRCT findings did not show differences between Groups Bef and Aft.
Discussion
We combined 3 populations, i.e. those reported by Hamaguchi et al. 12) , Chonan et al. 13) , and newly enrolled workers, because all 3 populations showed essentially the same dose-dependent effects of indium on the respiratory system. Consequently, the internal validity of this study may have been improved in terms of assessing the causal relationships between indium exposure and its effects on the lungs.
The geometric means and the prevalence of serum biomarkers of interstitial lung changes (KL-6, SP-D) were significantly higher in current exposure workers than in no exposure workers. The markers of inflammation such as the CRP and WBC count did not show any differences among the groups of current, former and no exposure workers. These findings were compatible with the results of two epidemiological studies 12, 13) and 5 clinical case reports [7] [8] [9] [10] [11] . As shown in Table 3 and Figs. 1a and 1c , the dose-effect and dose-response relationships between indium exposure and the biological effect indices of interstitial lung changes were evident. KL-6 showed the sharpest dose-effect and dose-response relationships, and significantly increased in Groups 3 to 6. Based on these relationships, we believe that the concentration of In-S should be kept at less than 3 ng/ml to prevent interstitial damage to the lungs from indium exposure. Other occupational toxicants inducing interstitial lung damage may be potential candidates for inducing high KL-6. There are only two previous articles evaluating the association between occupational diseases and KL-6. Inoue et al. showed that serum KL-6 in 26 patients with chronic pulmonary berylliosis was significantly higher than in 15 beryllium-sensitized workers with no berylliosis or 32 control workers 21) . Abe et al. compared the KL-6 levels of asbestos-exposed workers with or without pleural plaque, and stated that KL-6 was higher in 17 workers with pleural plaque than in 16 workers Abbreviations and symbols: see Table 3 . without pleural plaque, although the difference was not statistically significant 22) . Thus, exposure to beryllium and asbestos may be a potential cause of high KL-6, but no former or current exposure workers had an occupational history of asbestos or beryllium exposure. Hamaguchi et al. disclosed that no difference in KL-6 was seen between indium no exposure workers with and without an occupational history of exposure to nonferrous metals other than indium 12) . Therefore, it is unlikely that exposure to occupational toxicants other than indium was a cause of KL-6 elevation observed in this study.
KL-6 was significantly higher in non-smoking current exposure workers than in smoking current exposure workers (data not shown). The former exposure workers showed a similar trend, but the difference was not significant. However, no difference in KL-6 was found between non-smoking and smoking no exposure workers, and Kobayashi et al. 23) reported that KL-6 was unaffected by smoking status. If smoking is a potential suppresser of KL-6 release from type II alveolar pneumocytes and bronchiolar epithelial cells, KL-6 in smoking workers with indium exposure might be underestimated.
Improvement of the working conditions caused a reduction of In-S and of the effects on the lung interstitium, as shown in Table 5 . This improvement may be evidence of the specificity of a causal association between indium exposure and its effects on the lungs. We did not assess intra-individual changes of exposure and effect indices in the current and former exposure workers between the periods before and after the improvement of working conditions because we judged it unreasonable to assess the efficacy of the improvement based on the findings that the In-S concentration was still higher and the effects on the lungs were prolonged in the former exposed workers, and based on an animal experiment indicating a long biological half-life for indium in the lungs 19) . In addition to the current exposure workers, the former exposure workers also showed significantly higher In-S, KL-6 and interstitial lung changes than the no exposure workers, and the dose-dependent effects on the lungs were significant. Approximately a quarter of the former workers had irreversible interstitial changes in the lungs and symptoms of cough and/or sputum. These findings indicate that the indium burden in the lungs may slowly decrease after indium exposure stops, but that indium accumulated in the lungs actively and continuously generates effects in the lungs. These findings are consistent with the prolonged pulmonary inflammation and slow elimination of indium from the lungs that were seen in rats and mice exposed to 0.1 or 0.3 mg/m 3 of indium phosphide for 21 or 22 wk and to room air for approximately 80 wk 19) . A long-term follow-up of the former exposure workers is needed to determine the asyet-unknown prognosis of the effects of indium on the lungs.
This study had several limitations. It is likely that workers who were eligible for participation, but who had left or retired from indium jobs due to indium-induced respiratory effects, could not participate in our epidemiological study, because the existence of indiuminduced respiratory effects was not known until our first epidemiological study 12) . Though this limitation may lead our study to produce results that are underestimated, we believe that the survival selection bias was small because the dose-effect and dose-response relationships between indium exposure and interstitial lung effects were evident in both current exposure and former exposure workers.
Additionally, there was some information bias due to differences in where and when the first cross-sectional observation was conducted at each factory. In-S was measured at two different laboratories, and the chest HRCT was taken at a hospital near each factory. The resolving power of the CT scanner was different at each hospital. Although unified instructions for performing chest CT were given to the hospitals, and two pulmonologists read all of the HRCT films, some measurement bias may have been unavoidable. The serum biochemical indices were determined in one nationwide clinical laboratory, and pulmonary function tests were performed by trained staff at our research unit. Therefore, measurement bias in the serum biochemistry and pulmonary function test is likely to have been small.
In 1964, the advisory committee to the US Surgeon General on "Cigarette Smoking and Lung Cancer" established the "Criteria for causal association in epidemiology", which included 5 criteria: "Temporal relationship", "Strength of association", "Consistency of association", "Coherence of association", and "Specificity of association".
The first criterion, "Temporal relationship", i.e. "Exposure always precedes the outcome", must be absolutely fulfilled to show a causal association. Indium exposure in the general environment is negligible, and occupational exposure is the only source of indium exposure. Thus, the temporal relationship was adequately fulfilled. The strength of association is very clear. Exposed workers showed higher levels of indium with a higher prevalence of outcome indices related to interstitial changes of the lungs, such as KL-6 and SP-D. The doseeffect and dose-response relationships between In-S and the outcome indices were also significant, and pronounced. In this study, we combined three sets of baseline data, namely data reported by Hamaguchi et al. 12) , those reported by Chonan et al. 13) , and other newly collected unpublished data, because all three sets of data showed the same consequences. Seven indium lung cases have been discovered [7] [8] [9] [10] [11] . Therefore, the consistency of association criterion seems to be fulfilled. The data were obtained only in Japan, because indium demand in countries other than Japan is small 1) . It may not be possible to measure the incidence of indium lung effects or to conduct an epidemiological study in the USA or European countries. It is well known that the inhalation of hardly soluble hazardous particles, such as crystalline silica, asbestos, and so on, induces pneumoconiosis. In animal experiments, intra-tracheal instillation of indium compounds induces pneumonitis, proliferation of fibrous tissues, pulmonary fibrosis, and other lung diseases [3] [4] [5] [6] . The results of our study are consistent with these information. Thus, the coherence of association criterion seems to be fulfilled. In newly exposed workers who started their indium job after changes in working conditions were made (Group Aft), the indium exposure level was considerably reduced, and the interstitial effects on the lungs were reduced. Therefore, we think that specificity of association may have been established.
In a strict sense, the causal association between indium exposure and effects on the lungs has not been completely proven, but the results of the present study strongly support the causal association between indium exposure and effects on the lungs, and we think it has been substantially established.
In conclusion, the concentration of In-S should be kept at less than 3 ng/ml to prevent interstitial lung damage from indium exposure. Follow-up observations are now in progress to elucidate the biological kinetics of In-S and the prognosis of the effects on the lungs.
